Active Ingredient(s): Mesalamine, 5-ASA
FDA Approved: * January 5, 2001
Category: Anti-Inflammatory

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Canasa Overview

Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease.[1] It is generally used for mildly to moderately severe disease.[1] It is taken by mouth or rectally.[1] The formulations which are taken by mouth appear to be similarly effective.[4] Common side effects include headache, nausea, abdominal pain, and feve...

Read more Canasa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Canasa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mesalamine, 5-ASA
  • Capsule, Delayed Release: 400mg
  • Capsule, Extended Release: 250mg, 375mg, 500mg
  • Enema: 4g/60ml, 4gm/60ml
  • Suppository: 1000mg, 1gm, 500mg
  • Tablet, Delayed Release: 1.2gm, 1.2mg, 400mg, 800mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Canasa: (4 results)

Sorted by National Drug Code
  • 54868-6147 Canasa 1000 mg/1 Rectal Suppository by Physicians Total Care, Inc.
  • 58914-501 Canasa 1000 mg/1 Rectal Suppository by Aptalis Pharma Us, Inc.
  • 65084-474 Canasa 1000 mg Rectal Suppository by Mckesson Rxpak Inc
  • 69110-010 Canasa 1000 mg Rectal Suppository by Endoceutics Inc.

Other drugs which contain Mesalamine, 5-ASA or a similar ingredient: (8 results)